Skip to main content
Log in

Northern blot analysis for detection and quantification of RNA in pancreatic cancer cells and tissues

  • Protocol
  • Published:

From Nature Protocols

View current issue Submit your manuscript

Abstract

Investigation of gene expression significantly contributes to our knowledge of the regulation and function of genes in many areas of biology. In this protocol, we describe how northern blot analysis is used to identify gene expression patterns at the RNA level in human cancer cells as well as in cancerous and normal tissues. RNA molecules are separated by gel electrophoresis and are subsequently transferred to a porous membrane by capillary action. Specific sequences in the RNA are detected on the membrane by molecular hybridization with radiolabeled nucleic acid probes. Despite the development of newer methods, such as real-time PCR, nuclease protection assays and microarrays, northern blot analysis is still a standard technique used in the detection and quantification of mRNA levels because it allows a direct comparison of the mRNA abundance between samples on a single membrane. This entire northern blotting protocol takes ∼4 d to complete.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2: Examples of RNA gels.
Figure 3: Upward capillary transfer.
Figure 4: Northern blot analysis of EGFR, EGF and TGF-α in the normal pancreas and pancreatic cancer.

Similar content being viewed by others

References

  1. Alwine, J.C., Kemp, D.J. & Stark, G.R. Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc. Natl. Acad. Sci. USA 74, 5350–5354 (1977).

    Article  CAS  Google Scholar 

  2. Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156–159 (1987).

    Article  CAS  Google Scholar 

  3. Welsch, T., Kleeff, J. & Friess, H. Molecular pathogenesis of pancreatic cancer: advances and challenges. Curr. Mol. Med. 7, 504–521 (2007).

    Article  CAS  Google Scholar 

  4. Kleeff, J. et al. Pancreatic cancer: from bench to 5-year survival. Pancreas 33, 111–118 (2006).

    Article  CAS  Google Scholar 

  5. Ramsay, G. et al. DNA chips: state-of-the art. Nat. Biotechnol. 16, 40–44 (1998).

    Article  CAS  Google Scholar 

  6. O'Driscoll, L. et al. The use of reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate specific gene expression in multidrug-resistant cells. Cytotechnology 12, 289–314 (1993).

    Article  CAS  Google Scholar 

  7. Friess, H. et al. Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol. Life Sci. 60, 1180–1199 (2003).

    Article  CAS  Google Scholar 

  8. Friess, H. et al. Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann. Surg. 234, 769–778 (2001); discussion 778–779.

    Article  CAS  Google Scholar 

  9. Grutzmann, R. et al. Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes. Oncogene 24, 5079–5088 (2005).

    Article  Google Scholar 

  10. Friess, H. et al. Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res. 53, 2704–2707 (1993).

    CAS  PubMed  Google Scholar 

  11. Friess, H. et al. Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105, 1846–1856 (1993).

    Article  CAS  Google Scholar 

  12. Korc, M. et al. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J. Clin. Invest. 90, 1352–1360 (1992).

    Article  CAS  Google Scholar 

  13. Ramadori, G., Sipe, J.D. & Colten, H.R. Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J. Immunol. 135, 3645–3647 (1985).

    CAS  PubMed  Google Scholar 

  14. Chirgwin, J.M. et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294–5299 (1979).

    Article  CAS  Google Scholar 

  15. Hodgson, C.P. & Fisk, R.Z. Hybridization probe size control: optimized 'oligolabelling'. Nucleic Acids Res. 15, 6295 (1987).

    Article  CAS  Google Scholar 

  16. Feinberg, A.P. & Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6–13 (1983).

    Article  CAS  Google Scholar 

  17. Feinberg, A.P. & Vogelstein, B. 'A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity'. Addendum. Anal. Biochem. 137, 266–267 (1984).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jörg Kleeff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Streit, S., Michalski, C., Erkan, M. et al. Northern blot analysis for detection and quantification of RNA in pancreatic cancer cells and tissues. Nat Protoc 4, 37–43 (2009). https://doi.org/10.1038/nprot.2008.216

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nprot.2008.216

  • Springer Nature Limited

This article is cited by

Navigation